Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45

Biocon

BSE: 532523  |  NSE: BIOCON  |  ISIN: INE376G01013  |  Pharmaceuticals
    
 

Have a tip or information to share on Biocon?


Message   Positive opinion   Negative opinion   Query   Grievance   
View by : 
Latest Messages   |   Most Active   |   Top Rated   |   Top Tracked   |   Active Boarders
Go to page:  First    [   ]  Previous    5    6    7    8    9    10    Next  [  ]    
Sort by:   
Positive Opinions   |   Negative Opinions   |   Queries   |   Grievances   |   ALL
16 Oct 2009 14:09

Q2FY2009-10 results

Posted by : sarath13in
Price when posted : BSE: Rs 275.20 ( 5.06 % ), NSE: Rs. 274.25 ( 4.66 % )

my sentiments exactly brother, i have steadyly accumulated 7910 shares over the last 5 years and every one was making fun of me , no one can imagine in the wildest dreams that this stock will achieve the first target price of Rs 4765 by mar 2011 purely on the fundamental earnings and forward eps prospects , if the punters and operators get into this stock then sky is the limit, Check out this link kiran majumdars interview of 22 minutes on 7 sep, buddy we are in for exponential growth , soon we will be talking profits in terms of several crores.tubaah(dot)com/details.php?video_id=101916...

16 Oct 2009 14:01

Q2FY2009-10 results

Posted by : sanecouncel.
Price when posted : BSE: Rs 275.20 ( 5.06 % ), NSE: Rs. 275.55 ( 5.15 % )

dear , this is a false story, dont believe this. how can a man see inside a locked BOX....

16 Oct 2009 13:31

Q2FY2009-10 results

Posted by : Alokbhatt74
Price when posted : BSE: Rs 273.00 ( 4.22 % ), NSE: Rs. 273.05 ( 4.20 % )

Which means what?...

16 Oct 2009 13:22

Q2FY2009-10 results

Posted by : sanecouncel.
Price when posted : BSE: Rs 273.60 ( 4.45 % ), NSE: Rs. 274.30 ( 4.67 % )

there was a locked BOX made of steel for auction. no one was ready to pay price for that ordinary old steel BOX more than rs250-300 as tere was enough boxes available at that rate in market.
there was a man who has power to see inside the covered area.... god gifted power. he noticed that there is a 400 ct dimond neckless is inside the box. he came out and payed rs500 for that box... all public start laughing on this foolish act but only that man knew who is fool?...

14 Oct 2009 17:17

Q2FY2009-10 results

Posted by : tms2006
Price when posted : BSE: Rs 265.25 ( 0.95 % ), NSE: Rs. 264.95 ( 0.74 % )

which means the scrip will cross 300 soon........

14 Oct 2009 15:42

Q2FY2009-10 results

Posted by : O_BOND
Price when posted : BSE: Rs 266.10 ( 1.27 % ), NSE: Rs. 265.80 ( 1.06 % )

Motilal Oswal has come out with its earning estimates for Pharmaceutical sector for the quarter ended September 2009. According to the research firm, Biocon`s September quarter net sales are expected to go up by 19% to Rs 526.6 crore on YoY basis.
The company`s profit after tax is expected to go up by 128.3% to Rs 57.5 crore on YoY basis.09...

14 Oct 2009 14:19

keep on accumulating

Posted by : tms2006
Price when posted : BSE: Rs 265.10 ( 0.89 % ), NSE: Rs. 264.40 ( 0.53 % )

the counter has consolidated, now its time for the up move, keep on buying on dips...............

09 Oct 2009 15:54

Buy

Posted by : lmj
Price when posted : BSE: Rs 256.75 ( -1.33 % ), NSE: Rs. 257.25 ( -1.10 % )

This counter has appriciated a lot and it is not fundamentaly strong....

09 Oct 2009 12:54

buy biocon

Posted by : Guest
Price when posted : BSE: Rs 262.45 ( 0.86 % ), NSE: Rs. 263.20 ( 1.19 % )

all promise only , we have to see some ground reality. dont live in dream.reality may hurt if you go too much higher in dream...

08 Oct 2009 11:42

BSE Announcements on Biocon

Posted by : Guest
Price when posted : BSE: Rs 264.25 ( 1.25 % ), NSE: Rs. 264.70 ( 1.28 % )

sure i do not know the truth but i guess that i might be correct when picture will get clear.they were looking for a plant in vizag SEZ for the same reason...scarcity of water.
now production of oral insulin for indian market and non-regulated market is just few months away , therefore it may be the case
...

08 Oct 2009 11:17

SUVEN KYON BUYER FREEZE HAI?

Posted by : tara23
Price when posted : BSE: Rs 260.65 ( -0.13 % ), NSE: Rs. 261.30 ( -0.02 % )

yes u r very much correct....

08 Oct 2009 10:56

SUVEN KYON BUYER FREEZE HAI?

Posted by : sanecouncel.
Price when posted : BSE: Rs 261.00 ( 0.00 % ), NSE: Rs. 261.50 ( 0.06 % )

yes i think so... but for that a new joker like forex loss is required.wait for correction...

08 Oct 2009 10:50

BSE Announcements on Biocon

Posted by : Guest
Price when posted : BSE: Rs 261.70 ( 0.27 % ), NSE: Rs. 260.55 ( -0.31 % )

yar what crazy analysis. Why would they buy a API production plant because of water scarcity? For the same amount they can buy 100 tankers per day for 5-10 years to deliver water in bangalore, esp after these floods....

07 Oct 2009 16:58

SUVEN KYON BUYER FREEZE HAI?

Posted by : tara23
Price when posted : BSE: Rs 261.00 ( -0.32 % ), NSE: Rs. 261.35 ( -0.21 % )

yes atleast then the stock may show some upside... so within 18 months. u can get a good chance at good price when the market is very very bad......

07 Oct 2009 16:52

SUVEN KYON BUYER FREEZE HAI?

Posted by : sanecouncel.
Price when posted : BSE: Rs 261.00 ( -0.32 % ), NSE: Rs. 261.35 ( -0.21 % )

pyare popat ... kiran is talking about launching the oral insulin drug....not MOLECLUE anymore,,,it is a DRUG,,,,IN 105 ORAL INSULIN

READ THIS NEWS

Sept. 29 (Bloomberg) -- Biocon Ltd, India’s biggest biotechnology company, plans to begin commercial production of an insulin pill within 18 months, giving millions of diabetes sufferers a new way of controlling blood-sugar

The orally administered hormone is in the final of three stages of patient studies that drugs usually require for regulatory approval, Biocon Managing Director Kiran Mazumdar- Shaw said in an interview in Kuala Lumpur today

If successful, the tablet would help the Bangalore-based company tap a global insulin market which New York-based MarketResearc/com predicts will grow 15 percent annually through 2010, Pen-like injections, syringes and pumps dominate the market, and needle-free methods of delivering the drug have proven elusive, Pfizer Inc withdrew Exubera, an inhaled product, in 2007 after it failed to catch on with doctors and patients,

“This is a product that we see to be a game-changer,” Mazumdar-Shaw, 53, said. “It has huge potential and certainly can be a multibillion dollar blockbuster”

HENCE IF YOU DO NOT HAVE THIS STOCK, STILL GO AHEAD AND BUY AS IT IS AVAILABLE AT 2004 PRICE
WHO WILL TAKE INJECTION/PEN PRICK PAIN?...